Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT03198026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03282396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03295240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
ClinicalTrials.gov study NCT05694312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
ClinicalTrials.gov study NCT03229200. IPD Sharing: NO. Countries: 17. Publications: 0.
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
ClinicalTrials.gov study NCT02582320. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction
ClinicalTrials.gov study NCT03734198. IPD Sharing: NO. Countries: 1. Publications: 0.
REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
ClinicalTrials.gov study NCT05621148. IPD Sharing: NO. Countries: 1. Publications: 0.
Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL
ClinicalTrials.gov study NCT04685915. IPD Sharing: YES. Countries: 0. Publications: 0.
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
ClinicalTrials.gov study NCT03581942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
ClinicalTrials.gov study NCT04876092. IPD Sharing: YES. Countries: 4. Publications: 0.
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04802590. IPD Sharing: NO. Countries: 3. Publications: 0.
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
ClinicalTrials.gov study NCT03731234. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02950220. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lympho
ClinicalTrials.gov study NCT05105841. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02556892. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Orelabrutinib in CLL/SLL Patients Who Are Slowly Responding to Ibrutinib
ClinicalTrials.gov study NCT05491044. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma
ClinicalTrials.gov study NCT03093831. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Activity of SNX-5422 Plus Ibrutinib in CLL
ClinicalTrials.gov study NCT02914327. IPD Sharing: NO. Countries: 1. Publications: 0.
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
ClinicalTrials.gov study NCT04043845. IPD Sharing: YES. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.